Search Results 191-200 of 40303 for Two-phase

  1. Immune Thrombocytopenia Clinical Trials - Mayo Clinic Research

    The purpose of the phase 1 part of this study is to evaluate how well pirtobrutinib is tolerated and what side effects may occur. The phase 2 part of the study ...

  2. Projects - Molecular Analysis of Human Diseases Laboratory - Mayo Clinic Research

    Our studies have supported the development and completion of phase 1 and phase 2 clinical trials of endoxifen therapy for ERα+ metastatic breast cancer, as ...

  3. Morning-after pill - Mayo Clinic

    Most morning-after pills contain one of two types of medicine: levonorgestrel (Plan B One-Step, Fallback Solo, others) or ulipristal acetate (ella, Logilia).

  4. A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  5. Study of Ociperlimab in Combination With Tislelizumab in Advanced Solid Tumors - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  6. APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA) - Mayo Clinic

    Mayo Clinic will be participating in both Part A (Phase 1) & (Phase 2) B of the study. Participation eligibility. Participant eligibility includes age ...

  7. A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma (GOLSEEK-2) - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS - Mayo Clinic

    This is a phase 1/2 study to evaluate the combination of vadastuximab talirine (SGN-CD33A; 33A) and azacitidine in subjects with previously untreated ...

  9. A Study Of IBI363 In Subjects With Advanced Solid Malignancies - Mayo Clinic

    About this study. This is a Phase 2, open-label, multicenter study designed to evaluate the efficacy, safety and tolerability of IBI363 (study drug) in ...

  10. Nonalcoholic Steatohepatitis Clinical Trials - Mayo Clinic Research

    ... stage 2 or 3. The primary objective for PART 2 of this study is to ... It will consist of 2 phases: - Randomized Double-Blind Phase - Open Label Phase (optional).